Graham Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
40,364
+23,317
| +137% | +$306K | 0.01% | 752 |
|
|
2025
Q1 | $375K | Sell |
17,047
-1,368
| -7% | -$30.1K | 0.01% | 883 |
|
|
2024
Q4 | $492K | Buy |
18,415
+2,516
| +16% | +$67.2K | 0.01% | 716 |
|
|
2024
Q3 | $424K | Sell |
15,899
-18,612
| -54% | -$497K | 0.01% | 649 |
|
|
2024
Q2 | $622K | Buy |
34,511
+7,669
| +29% | +$138K | 0.01% | 492 |
|
|
2024
Q1 | $490K | Buy |
+26,842
| New | +$490K | 0.01% | 613 |
|
|
2022
Q4 | – | Sell |
-40,494
| Closed | -$398K | – | 1103 |
|
|
2022
Q3 | $398K | Buy |
+40,494
| New | +$398K | 0.02% | 805 |
|